What is Terason?
Terason operates as a pioneering manufacturer of portable ultrasound machines, engineered to enhance clinical efficacy and operational productivity across diverse medical environments. By integrating proprietary technologies such as Dynamic Depth Resolution and Enhanced Needle Visualization, the company addresses critical diagnostic needs in emergency medicine, cardiology, and musculoskeletal care. Their flagship product line, including the uSmart 3300 NexGen and uSmart 3200T, positions Terason as a key player in the shift toward point-of-care ultrasound (POCUS) adoption. Beyond hardware, the firm provides comprehensive educational programs and technical support, ensuring that healthcare providers can maximize the utility of their imaging systems in high-pressure clinical settings.
How much funding has Terason raised?
Terason has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Terason
PPP
Public-Private Partnership
What's next for Terason?
Following this late-stage financing, Terason is well-positioned to accelerate its market penetration and refine its research and development pipeline. The infusion of capital will likely be directed toward expanding the reach of its uSmart series and potentially exploring new frontiers in AI-assisted image interpretation. As the demand for portable, high-resolution diagnostic tools grows, Terason's focus on technological innovation and user-centric design will be essential for maintaining its competitive edge. The company is expected to leverage this financial backing to strengthen its global distribution networks and enhance its service infrastructure, ensuring long-term sustainability in the rapidly evolving medical device sector.
See full Terason company page
